The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
MRI has emerged as one of several urgently needed candidate disease progression biomarkers for the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), not least due to its unique ability to non-invasively assess structural and functional cerebral pathology. We sought to identify the exte...
Main Authors: | Menke, R, Proudfoot, M, Talbot, K, Turner, M |
---|---|
פורמט: | Journal article |
יצא לאור: |
Elsevier
2017
|
פריטים דומים
-
The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
מאת: R.A.L. Menke, et al.
יצא לאור: (2018-01-01) -
Imaging cerebral activity in amyotrophic lateral sclerosis
מאת: Proudfoot, M, et al.
יצא לאור: (2019) -
Motor system biomarkers in amyotrophic lateral sclerosis
מאת: Edmond, EC, et al.
יצא לאור: (2019) -
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.
מאת: Menke, R, et al.
יצא לאור: (2014) -
Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
מאת: Malcolm Proudfoot, et al.
יצא לאור: (2019-01-01)